Cargando…

Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen

Early‐onset osteoporosis (EOOP), characterized by low bone mineral density (BMD) and fractures, affects children, premenopausal women and men aged <50 years. EOOP may be secondary to a chronic illness, long‐term medication, nutritional deficiencies, etc. If no such cause is identified, EOOP is re...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Alice, Mäkitie, Riikka E., Hartmann, Markus A., Fratzl‐Zelman, Nadja, Zillikens, M. Carola, Kornak, Uwe, Søe, Kent, Mäkitie, Outi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542053/
https://www.ncbi.nlm.nih.gov/pubmed/35949115
http://dx.doi.org/10.1002/jbmr.4668
_version_ 1784804064404439040
author Costantini, Alice
Mäkitie, Riikka E.
Hartmann, Markus A.
Fratzl‐Zelman, Nadja
Zillikens, M. Carola
Kornak, Uwe
Søe, Kent
Mäkitie, Outi
author_facet Costantini, Alice
Mäkitie, Riikka E.
Hartmann, Markus A.
Fratzl‐Zelman, Nadja
Zillikens, M. Carola
Kornak, Uwe
Søe, Kent
Mäkitie, Outi
author_sort Costantini, Alice
collection PubMed
description Early‐onset osteoporosis (EOOP), characterized by low bone mineral density (BMD) and fractures, affects children, premenopausal women and men aged <50 years. EOOP may be secondary to a chronic illness, long‐term medication, nutritional deficiencies, etc. If no such cause is identified, EOOP is regarded primary and may then be related to rare variants in genes playing a pivotal role in bone homeostasis. If the cause remains unknown, EOOP is considered idiopathic. The scope of this review is to guide through clinical and genetic diagnostics of EOOP, summarize the present knowledge on rare monogenic forms of EOOP, and describe how analysis of bone biopsy samples can lead to a better understanding of the disease pathogenesis. The diagnostic pathway of EOOP is often complicated and extensive assessments may be needed to reliably exclude secondary causes. Due to the genetic heterogeneity and overlapping features in the various genetic forms of EOOP and other bone fragility disorders, the genetic diagnosis usually requires the use of next‐generation sequencing to investigate several genes simultaneously. Recent discoveries have elucidated the complexity of disease pathogenesis both regarding genetic architecture and bone tissue‐level pathology. Two rare monogenic forms of EOOP are due to defects in genes partaking in the canonical WNT pathway: LRP5 and WNT1. Variants in the genes encoding plastin‐3 (PLS3) and sphingomyelin synthase 2 (SGMS2) have also been found in children and young adults with skeletal fragility. The molecular mechanisms leading from gene defects to clinical manifestations are often not fully understood. Detailed analysis of patient‐derived transiliac bone biopsies gives valuable information to understand disease pathogenesis, distinguishes EOOP from other bone fragility disorders, and guides in patient management, but is not widely available in clinical settings. Despite the great advances in this field, EOOP remains an insufficiently explored entity and further research is needed to optimize diagnostic and therapeutic approaches. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
format Online
Article
Text
id pubmed-9542053
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95420532022-10-14 Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen Costantini, Alice Mäkitie, Riikka E. Hartmann, Markus A. Fratzl‐Zelman, Nadja Zillikens, M. Carola Kornak, Uwe Søe, Kent Mäkitie, Outi J Bone Miner Res Review Early‐onset osteoporosis (EOOP), characterized by low bone mineral density (BMD) and fractures, affects children, premenopausal women and men aged <50 years. EOOP may be secondary to a chronic illness, long‐term medication, nutritional deficiencies, etc. If no such cause is identified, EOOP is regarded primary and may then be related to rare variants in genes playing a pivotal role in bone homeostasis. If the cause remains unknown, EOOP is considered idiopathic. The scope of this review is to guide through clinical and genetic diagnostics of EOOP, summarize the present knowledge on rare monogenic forms of EOOP, and describe how analysis of bone biopsy samples can lead to a better understanding of the disease pathogenesis. The diagnostic pathway of EOOP is often complicated and extensive assessments may be needed to reliably exclude secondary causes. Due to the genetic heterogeneity and overlapping features in the various genetic forms of EOOP and other bone fragility disorders, the genetic diagnosis usually requires the use of next‐generation sequencing to investigate several genes simultaneously. Recent discoveries have elucidated the complexity of disease pathogenesis both regarding genetic architecture and bone tissue‐level pathology. Two rare monogenic forms of EOOP are due to defects in genes partaking in the canonical WNT pathway: LRP5 and WNT1. Variants in the genes encoding plastin‐3 (PLS3) and sphingomyelin synthase 2 (SGMS2) have also been found in children and young adults with skeletal fragility. The molecular mechanisms leading from gene defects to clinical manifestations are often not fully understood. Detailed analysis of patient‐derived transiliac bone biopsies gives valuable information to understand disease pathogenesis, distinguishes EOOP from other bone fragility disorders, and guides in patient management, but is not widely available in clinical settings. Despite the great advances in this field, EOOP remains an insufficiently explored entity and further research is needed to optimize diagnostic and therapeutic approaches. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). John Wiley & Sons, Inc. 2022-09-11 2022-09 /pmc/articles/PMC9542053/ /pubmed/35949115 http://dx.doi.org/10.1002/jbmr.4668 Text en © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review
Costantini, Alice
Mäkitie, Riikka E.
Hartmann, Markus A.
Fratzl‐Zelman, Nadja
Zillikens, M. Carola
Kornak, Uwe
Søe, Kent
Mäkitie, Outi
Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title_full Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title_fullStr Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title_full_unstemmed Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title_short Early‐Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen
title_sort early‐onset osteoporosis: rare monogenic forms elucidate the complexity of disease pathogenesis beyond type i collagen
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542053/
https://www.ncbi.nlm.nih.gov/pubmed/35949115
http://dx.doi.org/10.1002/jbmr.4668
work_keys_str_mv AT costantinialice earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT makitieriikkae earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT hartmannmarkusa earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT fratzlzelmannadja earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT zillikensmcarola earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT kornakuwe earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT søekent earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen
AT makitieouti earlyonsetosteoporosisraremonogenicformselucidatethecomplexityofdiseasepathogenesisbeyondtypeicollagen